Up, Up, and Away
A business analyst rated Baxter stock a strong BUY, as the PD market has an attractive growth rate in the range of 5% to 6%, and the option is flexible and allows a more normal life.
Read the full article » | Posted 07-14-2017
Related Articles
- Baxter ASN Presence, 2018 Posted 10-05-2026
- Fresenius Kidney Care Reports PD Breakthroughs Posted 10-05-2026
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026